BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22726630)

  • 1. Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.
    Parvez B; Vaglio J; Rowan S; Muhammad R; Kucera G; Stubblefield T; Carter S; Roden D; Darbar D
    J Am Coll Cardiol; 2012 Aug; 60(6):539-45. PubMed ID: 22726630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion.
    Parvez B; Shoemaker MB; Muhammad R; Richardson R; Jiang L; Blair MA; Roden DM; Darbar D
    Heart Rhythm; 2013 Jun; 10(6):849-55. PubMed ID: 23428961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of obstructive sleep apnea influences the effect of genotype on response to anti-arrhythmic drug therapy for atrial fibrillation.
    Goyal SK; Wang L; Upender R; Darbar D; Monahan K
    J Clin Sleep Med; 2014 May; 10(5):503-7. PubMed ID: 24910551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variants and response to atrial fibrillation ablation.
    Shoemaker MB; Bollmann A; Lubitz SA; Ueberham L; Saini H; Montgomery J; Edwards T; Yoneda Z; Sinner MF; Arya A; Sommer P; Delaney J; Goyal SK; Saavedra P; Kanagasundram A; Whalen SP; Roden DM; Hindricks G; Ellis CR; Ellinor PT; Darbar D; Husser D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):296-302. PubMed ID: 25684755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation.
    Benjamin Shoemaker M; Muhammad R; Parvez B; White BW; Streur M; Song Y; Stubblefield T; Kucera G; Blair M; Rytlewski J; Parvathaneni S; Nagarakanti R; Saavedra P; Ellis CR; Patrick Whalen S; Roden DM; Darbar R D
    Heart Rhythm; 2013 Mar; 10(3):394-400. PubMed ID: 23178686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common variant on chromosome 4q25 is associated with prolonged PR interval in subjects with and without atrial fibrillation.
    Kolek MJ; Parvez B; Muhammad R; Shoemaker MB; Blair MA; Stubblefield T; Kucera GA; Denny JC; Roden DM; Darbar D
    Am J Cardiol; 2014 Jan; 113(2):309-13. PubMed ID: 24161141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation.
    Husser D; Adams V; Piorkowski C; Hindricks G; Bollmann A
    J Am Coll Cardiol; 2010 Feb; 55(8):747-53. PubMed ID: 20170812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.
    Darbar D; Motsinger AA; Ritchie MD; Gainer JV; Roden DM
    Heart Rhythm; 2007 Jun; 4(6):743-9. PubMed ID: 17556195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.
    Parvez B; Chopra N; Rowan S; Vaglio JC; Muhammad R; Roden DM; Darbar D
    J Am Coll Cardiol; 2012 Jan; 59(1):49-56. PubMed ID: 22192668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation.
    Ritchie MD; Rowan S; Kucera G; Stubblefield T; Blair M; Carter S; Roden DM; Darbar D
    J Am Coll Cardiol; 2012 Sep; 60(13):1173-81. PubMed ID: 22818067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 4q25 variants and recurrence after second-generation cryoballoon ablation in patients with paroxysmal atrial fibrillation.
    Miyazaki S; Ebana Y; Liu L; Nakamura H; Hachiya H; Taniguchi H; Takagi T; Kajiyama T; Watanabe T; Igarashi M; Kusa S; Niida T; Iesaka Y; Furukawa T
    Int J Cardiol; 2017 Oct; 244():151-157. PubMed ID: 28637626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.
    Kääb S; Darbar D; van Noord C; Dupuis J; Pfeufer A; Newton-Cheh C; Schnabel R; Makino S; Sinner MF; Kannankeril PJ; Beckmann BM; Choudry S; Donahue BS; Heeringa J; Perz S; Lunetta KL; Larson MG; Levy D; MacRae CA; Ruskin JN; Wacker A; Schömig A; Wichmann HE; Steinbeck G; Meitinger T; Uitterlinden AG; Witteman JC; Roden DM; Benjamin EJ; Ellinor PT
    Eur Heart J; 2009 Apr; 30(7):813-9. PubMed ID: 19141561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Obstructive Sleep Apnea and a Common Variant at Chromosome 4q25 to Atrial Fibrillation.
    Patel NJ; Wells QS; Huang S; Upender RP; Darbar D; Monahan K
    Am J Cardiol; 2017 May; 119(9):1387-1391. PubMed ID: 28258728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort.
    Chalazan B; Mol D; Sridhar A; Alzahrani Z; Darbar SD; Ornelas-Loredo A; Farooqui A; Argos M; Daviglus ML; Konda S; Rehman J; Darbar D
    PLoS One; 2018; 13(4):e0194480. PubMed ID: 29624624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant rs2200733 and rs10033464 on chromosome 4q25 are associated with increased risk of atrial fibrillation after catheter ablation: Evidence from a meta-analysis.
    He J; Zhu W; Yu Y; Hu J; Hong K
    Cardiol J; 2018; 25(5):628-638. PubMed ID: 29240960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic loci on chromosomes 4q25, 7p31, and 12p12 are associated with onset of lone atrial fibrillation before the age of 40 years.
    Olesen MS; Holst AG; Jabbari J; Nielsen JB; Christophersen IE; Sajadieh A; Haunsø S; Svendsen JH
    Can J Cardiol; 2012; 28(2):191-5. PubMed ID: 22336519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation.
    Choi JI; Baek YS; Roh SY; Piccini JP; Kim YH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1904-1913. PubMed ID: 31393025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success.
    Choi EK; Park JH; Lee JY; Nam CM; Hwang MK; Uhm JS; Joung B; Ko YG; Lee MH; Lubitz SA; Ellinor PT; Pak HN
    J Am Heart Assoc; 2015 Aug; 4(8):e002046. PubMed ID: 26272656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Genetic Variants at the 4q25 Locus with Atrial Fibrillation in Indian Population.
    Bhanushali A; Nair A; Jagdale G; Suvarna T; Das BR
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27346453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.
    Ornelas-Loredo A; Kany S; Abraham V; Alzahrani Z; Darbar FA; Sridhar A; Ahmed M; Alamar I; Menon A; Zhang M; Chen Y; Hong L; Konda S; Darbar D
    JAMA Cardiol; 2020 Jan; 5(1):57-64. PubMed ID: 31774463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.